Provider and practice are certified in ProSomnus devices, serve in an educational capacity, is an industry leader and has exhibited the highest proficient use and exceptional knowledge of related Dental Sleep Medicine procedures.
Thank you for your interest in ProSomnus career opportunities. Please choose your department of interest:
Brian Dow is the Chief Financial Officer for ProSomnus® Sleep Technologies. Prior to joining ProSomnus in March of 2023, Mr. Dow served as Chief Financial Officer of Agendia N.V., a $60 million molecular diagnostics company, Senior Vice President and Chief Financial Officer of Pulse Biosciences (NASDAQ: PLSE), a development stage medical device company, and Principal Accounting Officer for Pacific Biosciences (NASDAQ: PACB), a commercial stage developer, manufacturer and provider of next generation sequencing instruments. Mr. Dow started his career as a manager with Ernst & Young.
Mr. Dow holds a B.S. in Management from the Georgia Institute of Technology and is recognized as a licensed certified public accountant by the Washington State Board of Accountancy.
This site uses cookies to provide the best possible user experience. This includes features to measure performance, reliability, and overall site health. By continuing on to use the site, you agree to accept these cookies.
